Clinical Pharmacology Department, Faculty of Medicine, Universidad de La Sabana, Campus del Puente del Común, Chía 250001, Cundinamarca, Colombia.
Evidence-Based Therapeutics Group, Department of Clinical Pharmacology, Faculty of Medicine, Universidad de La Sabana and Clínica Universidad de La Sabana, Campus del Puente del Común, Chía 250001, Cundinamarca, Colombia.
Int J Environ Res Public Health. 2024 Sep 24;21(10):1265. doi: 10.3390/ijerph21101265.
Chronic obstructive pulmonary disease (COPD) is a condition that significantly impacts both patients and healthcare systems. The management of COPD involves various pharmacological intervention strategies, and addressing the issue of low adherence to these strategies has become a subject of significant interest. In response to this concern, there has been a shift toward utilizing telemedicine and mobile applications. The primary objective of this scoping review is to delineate the usage of mobile applications to enhance medication adherence in adult patients with COPD. This study involved a search of databases such as Medline, Google Scholar, Cochrane, and ClinicalTrial.gov, focusing on the literature published in English and Spanish over the last decade. The selected studies assessed interventions involving mobile applications (mobile apps) designed to improve medication adherence. Four digital aids were identified and available on online platforms, mobile apps, or both: m-PAC, myCOPD, Wellinks mHealth, and Propeller Health. Propeller Health, in particular, is an app that directly measures medication adherence through electronic medication monitors attached to participants' inhalers. Opening the app was associated with higher odds of using control medications compared to participants who did not open the app. The findings suggest that these digital interventions serve as valuable tools to enhance patient adherence to treatment. Future research should focus on evaluating the effectiveness of different digital devices, such as digital inhalers and mobile applications, that directly measure medication adherence.
慢性阻塞性肺疾病（COPD）是一种严重影响患者和医疗体系的疾病。COPD 的管理涉及多种药物干预策略，而解决这些策略低依从性的问题已成为一个重要关注点。为了应对这一问题，人们开始转向使用远程医疗和移动应用程序。本综述的主要目的是描述移动应用程序在提高成年 COPD 患者药物依从性方面的应用。本研究在 Medline、Google Scholar、Cochrane 和 ClinicalTrials.gov 等数据库中进行了检索，重点是过去十年中发表的英文和西班牙文文献。所选研究评估了涉及旨在提高药物依从性的移动应用程序（移动应用程序）的干预措施。确定了四个数字辅助工具，并可在在线平台、移动应用程序或两者上使用：m-PAC、myCOPD、Wellinks mHealth 和 Propeller Health。特别是 Propeller Health 是一款通过连接到参与者吸入器上的电子药物监测器直接测量药物依从性的应用程序。与未打开应用程序的参与者相比，打开应用程序与使用控制药物的可能性更高相关。研究结果表明，这些数字干预措施是增强患者治疗依从性的有价值工具。未来的研究应集中评估不同数字设备（如直接测量药物依从性的数字吸入器和移动应用程序）的有效性。
